Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,843.21 +882.55 (+1.40%) CMC Crypto 200
1,346.62 -49.91 (-3.57%)
United Therapeutics Corporation (UTHR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 11.00B |
| Enterprise value | 8.71B |
| Trailing P/E | 11.80 |
| Forward P/E | 10.22 |
| PEG ratio (5-yr expected) | 0.81 |
| Price/sales (ttm) | 4.99 |
| Price/book (mrq) | 1.84 |
| Enterprise value/revenue | 3.74 |
| Enterprise value/EBITDA | 6.28 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.55 |
| 52-week change 3 | 0.75% |
| S&P500 52-week change 3 | 22.36% |
| 52-week high 3 | 261.54 |
| 52-week low 3 | 204.44 |
| 50-day moving average 3 | 233.44 |
| 200-day moving average 3 | 229.72 |
Share statistics
| Avg vol (3-month) 3 | 467.63k |
| Avg vol (10-day) 3 | 479.74k |
| Shares outstanding 5 | 47.06M |
| Implied shares outstanding 6 | 47.06M |
| Float 8 | 43.37M |
| % held by insiders 1 | 1.72% |
| % held by institutions 1 | 97.59% |
| Shares short (15 Apr 2024) 4 | 4.32M |
| Short ratio (15 Apr 2024) 4 | 7.97 |
| Short % of float (15 Apr 2024) 4 | 10.40% |
| Short % of shares outstanding (15 Apr 2024) 4 | 9.18% |
| Shares short (prior month 15 Mar 2024) 4 | 1.92M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 2:1 |
| Last split date 3 | 23 Sept 2009 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 42.31% |
| Operating margin (ttm) | 42.49% |
Management effectiveness
| Return on assets (ttm) | 11.22% |
| Return on equity (ttm) | 18.27% |
Income statement
| Revenue (ttm) | 2.33B |
| Revenue per share (ttm) | 49.73 |
| Quarterly revenue growth (yoy) | 25.10% |
| Gross profit (ttm) | N/A |
| EBITDA | 1.24B |
| Net income avi to common (ttm) | 984.8M |
| Diluted EPS (ttm) | 19.81 |
| Quarterly earnings growth (yoy) | 64.30% |
Balance sheet
| Total cash (mrq) | 2.99B |
| Total cash per share (mrq) | 63.62 |
| Total debt (mrq) | 732.8M |
| Total debt/equity (mrq) | 12.24% |
| Current ratio (mrq) | 4.41 |
| Book value per share (mrq) | 127.23 |
Cash flow statement
| Operating cash flow (ttm) | 978M |
| Levered free cash flow (ttm) | 607.29M |
© 2024 Yahoo. All rights reserved.